Press release
Personalized Medicine Bioinformatics Market Trends Support A 13.3% CAGR Outlook Through The Forecast Period
Personalized Medicine Bioinformatics Market
Projected Market Size and Growth Trajectory of Personalized Medicine Bioinformatics
The global personalized medicine bioinformatics market is anticipated to experience swift expansion, reaching a valuation of $7.23 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 13.3% over the forecast period. The surge in market size is largely fueled by the growing incorporation of bioinformatics into clinical workflows, increased investments in personalized medicine initiatives, and the broader adoption of AI-powered clinical decision support systems. Additionally, the rise in population-scale genomics analysis and the demand for interoperable health data platforms are significant contributors to market growth. Key trends shaping this market include the widespread use of AI-driven genomic analytics, multi-omics data integration, cloud-based bioinformatics services, pharmacogenomic decision support tools, and enhanced capabilities for scalable data interpretation.
The personalized medicine bioinformatics market size has grown rapidly in recent years. It will grow from $3.87 billion in 2025 to $4.4 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to expansion of next-generation sequencing usage, growing availability of genomic datasets, increasing research funding in precision medicine, rising demand for data-driven clinical insights, advances in bioinformatics algorithms.
Download a free sample of the personalized medicine bioinformatics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28294&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Main Drivers Behind the Expansion of Personalized Medicine Bioinformatics
One major factor boosting this market is the integration of bioinformatics technologies into everyday clinical practice. Medical professionals are increasingly relying on these tools to interpret complex genomic and multi-omics data, which helps tailor treatments to individual patients more effectively. The move toward precision medicine is encouraging healthcare systems to adopt interoperable platforms that facilitate seamless data sharing across various institutions.
Another important driver is the escalating investment in personalized medicine research and development programs. Pharmaceutical companies and biotech firms are allocating substantial resources to develop AI-enabled platforms that assist in drug discovery, patient stratification, and therapeutic decision-making. This investment trend not only accelerates innovation but also broadens the applications of bioinformatics in clinical diagnostics and treatment planning.
Key Participants Leading the Personalized Medicine Bioinformatics Market
The market landscape features a range of prominent companies actively shaping its progress. Notable players include F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., and OncoBox Inc.
In a significant development, May 2025 saw GeneDx Holdings Corp., a US-based provider specializing in genomic testing and diagnostics, acquire Fabric Genomics for up to $51 million. This acquisition aims to enhance GeneDx's decentralized, AI-driven genomic interpretation capabilities, accelerating rapid and scalable genomic diagnostics. Fabric Genomics offers AI-powered software focused on whole genome sequencing analysis, particularly for rare diseases, hereditary risks, and cancer diagnostics.
View the full personalized medicine bioinformatics market report:
https://www.thebusinessresearchcompany.com/report/personalized-medicine-bioinformatics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Trends Shaping the Future of Personalized Medicine Bioinformatics
Leading companies are increasingly focusing on the development of predictive analytics platforms within this space. These platforms utilize machine learning, sophisticated algorithms, and statistical modeling to analyze both historical and real-time datasets. The goal is to forecast disease progression and treatment responses, enabling healthcare providers to take proactive measures and refine therapies.
For example, in April 2023, Certis Oncology Solutions, a US-based biotech company, launched CertisAI, an AI/ML-driven predictive analytics platform. This technology harnesses big data and gene expression biomarkers to predict drug efficacy, aiming to accelerate drug discovery and the development of companion diagnostics specifically for precision oncology. The platform is undergoing validation as a service to assist biopharmaceutical firms in making informed decisions early in drug development and tailoring cancer treatments to individual patients.
Breakdown of Segments in the Personalized Medicine Bioinformatics Market
This market is segmented in several ways to cover the breadth of technologies, applications, and end users:
1) By Technology: Gene Sequencing, Pharmacogenomics, Microarray Technology, Artificial Intelligence-Driven Analytics Platforms, and Other Technologies
2) By Application: Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenomics, and Other Applications
3) By End User: Biotechnology and Pharmaceutical Companies, Clinical Diagnostics Laboratories, Hospitals and Academic Medical Centers, Contract Research Organizations and Biobanks, and Other End Users
Further subcategories include:
- Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)
- Pharmacogenomics: Drug-Gene Interaction Analysis, Adverse Drug Reaction Prediction, Biomarker Discovery, Personalized Drug Response Profiling
- Microarray Technology: DNA Microarray, RNA Microarray, Protein Microarray, Comparative Genomic Hybridization Microarray
- AI-Driven Analytics Platforms: Machine Learning-Based Platforms, Deep Learning-Based Platforms, Natural Language Processing Platforms, Predictive Analytics Platforms, Clinical Decision Support Systems
- Other Technologies: Proteomics Analysis, Metabolomics Analysis, Epigenomics Profiling, Bioinformatics Cloud Platforms
This detailed segmentation reflects the diverse range of approaches and applications within personalized medicine bioinformatics, underlining the market's complexity and potential for continued innovation.
Key enhancements in our 2026 market reports include:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Personalized Medicine Bioinformatics Market Trends Support A 13.3% CAGR Outlook Through The Forecast Period here
News-ID: 4612847 • Views: …
More Releases from The Business Research Company
Phosphor Screen Scanners Market Insights Highlight Segment Expansion And Market …
The phosphor screen scanners market stands at the cusp of remarkable growth, driven by technological advancements and increasing demand across medical and industrial sectors. As diagnostic and imaging needs evolve, this market is set to expand significantly, supported by innovations that enhance imaging precision and workflow efficiency.
Projected Market Value and Expansion of the Phosphor Screen Scanners Market
By 2030, the phosphor screen scanners market is anticipated to reach a…
Pompe Disease Market Analysis Highlights Growth To $2.48 Billion By 2030 At 6.8% …
The Pompe disease market is poised for robust expansion over the coming years, driven by advancements in treatment approaches and increased focus on early diagnosis. This overview explores the market's projected growth, key industry players, emerging trends, and detailed segmentation to provide a comprehensive understanding of this evolving therapeutic landscape.
Steady Growth Expected in the Pompe Disease Market Size Through 2030
Forecasts indicate the Pompe disease market will experience significant…
Pharyngitis Treatment Market Report Evaluates Growth Drivers, Challenges And Mar …
The pharyngitis treatment market is on a trajectory of significant growth, driven by advances in infection management and evolving healthcare delivery models. Increasing emphasis on precision medicine and digital healthcare tools is shaping the future landscape of treatment options for this common throat condition. Below, we explore the market's projected size, key players, emerging trends, and detailed segmentation.
Pharyngitis Treatment Market Size and Growth Outlook by 2030
The market for…
Polymerase Chain Reaction Molecular Diagnostics Market Study Highlights How Indu …
The polymerase chain reaction (PCR) molecular diagnostics sector is poised for significant expansion in the coming years. This market is expected to reach a value of $14.65 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4%. Several factors are driving this rapid growth, including the increasing use of point-of-care molecular diagnostics, heightened investments in personalized medicine, expanded genomic testing initiatives, rising demand for decentralized diagnostic solutions,…
More Releases for Bioinformatics
Bioinformatics Platforms Market Size Analysis by Application, Type, and Region: …
According to Market Research Intellect, the global Bioinformatics Platforms market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The bioinformatics platforms market is witnessing robust growth, fueled by the rising demand for advanced data analytics in…
Bioinformatics Market - Pioneering Solutions for Personalized Healthcare: Bioinf …
Newark, New Castle, USA: The "Bioinformatics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Bioinformatics Market: https://www.growthplusreports.com/report/bioinformatics-market/7618
This latest report researches the industry structure, sales, revenue, price and…
Bioinformatics Market - Analyzing Complexity, Unleashing Potential: Elevating Re …
Newark, New Castle, USA - new report, titled Bioinformatics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Bioinformatics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Bioinformatics market. The report offers an overview of the market, which briefly describes the…
Bioinformatics Market: Increasing Funding and Investments in Bioinformatics
In the field of genetics and genomics, bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a key role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and, more generally, in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals,…
Bioinformatics Market: Increasing Funding and Investments in Bioinformatics
In the field of genetics and genomics, bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a key role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and, more generally, in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals,…
Bioinformatics Market Research Report 2022 | AFFYMETRIX, INC., GENEVA BIOINFORMA …
Global Report on Bioinformatics Market Size, Status, Growth and Forecast 2021-2027.
The " Bioinformatics Market " research report is a valuable source of agile information for business methodologies. It provides an overview of the Bioinformatics industry, providing development research and definitive future value, income, market size, and supply and demand data (if applicable). The exam experts give you a point for each chain and retailer research of significant value. This market study provides extensive information to…
